Trial intelligence / Profile preview

PDO Thread Embedding Combined With Binh Vi Tablets in GERD

NCT07910656Completed

Sponsor
University of Medicine and Pharmacy of Ho Chi Minh City
Start
Mar 2026
Primary completion
Aug 2026
Countries
1
01

Overview

Randomised, open-label trial in gastroesophageal reflux disease (GERD) (2 arms), sponsored by University of Medicine and Pharmacy of Ho Chi Minh City. Primary endpoint: Gastroesophageal Reflux Disease Questionnaire Score at 4 weeks. Started Mar 2026; status: completed.

02

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT07910656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07910656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call